How One Experimental Drug May Be Defeating Ebola and Saving People

Since the worst Ebola outbreak on record ignited last December in West Africa, scientists have been racing to develop drugs and vaccines to combat the virus. Several experimental drugs have been given to patients, and a new study details how scientists think one of those drugs might neutralize the virus. The research focused on three antibodies, two of which are part of the experimental drug known as ZMapp. It hasn’t been officially tested in human clinical trials yet, but seven patients have received the drug so far this year. Though Ebola fatality rates sometimes approach 90 percent, five of the patients receiving ZMapp…
View More/Source Article